Use of altered informed consent in pragmatic clinical research. - Wikidata - wikimedia - TriplyDB

Use of altered informed consent in pragmatic clinical research.

Use of altered informed consent in pragmatic clinical research.

http://www.wikidata.org/entity/Q36397913

about

Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative.The Comprehensive Post-Acute Stroke Services (COMPASS) study: design and methods for a cluster-randomized pragmatic trial.Harmonization and streamlining of research oversight for pragmatic clinical trials The Food and Drug Administration and pragmatic clinical trials of marketed medical products.The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials.Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials.Exploring the ethical and regulatory issues in pragmatic clinical trials.Examining Provisions Related to Consent in the Revised Common Rule.PRagmatic trial Of Video Education in Nursing homes: The design and rationale for a pragmatic cluster randomized trial in the nursing home setting.Recruiting to preclinical Alzheimer's disease clinical trials through registries.Physicians' perspectives regarding pragmatic clinical trials.Proposals to Conduct Randomized Controlled Trials Without Informed Consent: a Narrative Review.Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory.Patients' beliefs regarding informed consent for low-risk pragmatic trials.Willingness to participate in pragmatic dialysis trials: the importance of physician decisional autonomy and consent approach.Reframing Consent for Clinical Research: A Function-Based Approach.Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation.Sources of Safety Data and Statistical Strategies for Design and Analysis: Real World Insights.Capacity, Vulnerability, and Informed Consent for Research.Ensuring respect for persons in COMPASS: a cluster randomised pragmatic clinical trial Where Did Informed Consent for Research Come From?Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol

P2860

Q27332116-CD732523-65DE-4800-8B5F-6FB0F5841F0B Q30249054-B2014381-2026-41E9-91EF-6B3BBA9DC71D Q33909494-40794970-128E-436F-9271-CB2FF222AA96 Q36117724-C2ABD702-136B-4CF2-A7E9-271C3CEC98CE Q36117819-7CF2FB5B-7045-40DF-8C93-F93652A29958 Q36326037-E4A4DC83-AC8F-432D-A47D-10E0CB1E380B Q36436428-B773A6E0-8653-4F40-BC14-2E0A4D6E1CFB Q36963233-649FB5EE-8E80-48D1-B9F8-D900FBF6A440 Q38665107-B8F67A24-4459-49ED-8A45-5FA23C77ADB1 Q38772771-27C3FA42-22DA-4917-9DBE-7A750949A904 Q38821788-57915D27-5F2C-4C83-94D4-C714B0025E7E Q38841758-9A1DD434-E9EF-43FE-971E-76408A7E94A2 Q38888145-FAB522CF-17D5-4B58-A4BF-F03531AF7E5D Q41711992-07D9F42D-EDBB-4E7A-BFDF-8D9D8496952D Q41711995-72C56866-843F-43A5-9C7A-34D96C05D088 Q42375084-68E6CE5E-E311-4124-9A57-F5DDFFDF34C7 Q49923167-B4FAFD9D-7ABE-4FA1-B09A-7D97D4B74C0D Q50354508-8C36E991-89D4-4BC7-BFAE-CECFD7631539 Q53282671-19EAE254-0D1A-4A24-89C2-D11FF0AC2AE6 Q55458665-D2113A4F-DF09-4DF9-A7D4-69194E08F9CA Q56524643-747B3B94-C10C-4A2C-8A0D-08187FEB0A20 Q56568771-2DAB87AF-8C53-45FD-BB12-B6E0D897FCB1 Q58656996-57872C40-CD85-48AF-BC89-C600D9637E60

P2860

Use of altered informed consent in pragmatic clinical research.

http://www.wikidata.org/entity/Q36397913

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Use of altered informed consent in pragmatic clinical research.

@ast

Use of altered informed consent in pragmatic clinical research.

@en

type

label

Use of altered informed consent in pragmatic clinical research.

@ast

Use of altered informed consent in pragmatic clinical research.

@en

prefLabel

Use of altered informed consent in pragmatic clinical research.

@ast

Use of altered informed consent in pragmatic clinical research.

@en

P1433

Q36397913-8000C6C5-255E-4C93-A84D-21CE758D9A3C

P1476

Q36397913-3CA0EECE-9968-41F3-B68A-36551E14ED36

P2093

Q36397913-1D1DFADD-1DF6-4F40-A791-A6F9CF2FBB56

Q36397913-205F85FA-E22D-4279-86C2-207835D71FF3

Q36397913-35CB05B1-C1BE-4FC6-B0B2-3638C054C712

Q36397913-3B4EFF41-F2C9-4C00-9AA1-A9D3C9B95D99

Q36397913-509344BB-0111-4045-BAEB-33BBC7EE0972

Q36397913-7BFF99ED-383F-40CB-8B3A-F814EEF16DE1

Q36397913-B02998EA-2C9D-4BDB-91F9-01CE813E4302

Q36397913-B37F8878-FBDF-4EC1-8083-019203252F3A

Q36397913-CC48ACEE-E0F8-420E-95C8-05A1587FFEF7

P2860

Q36397913-07E3B2DD-444E-49F3-90C4-5D1B33FB9E90

Q36397913-0CEF9C10-D817-470D-A227-69930DC00F6D

Q36397913-135DF2E2-B685-4F70-B8EC-357E634D1BEA

Q36397913-2D7ECB5B-27FC-49F5-99A0-6E3F4AEC45F9

Q36397913-3B49768B-D068-4841-BC3B-C9ABB8DC38EE

Q36397913-52FFD29D-3D2C-4396-9426-6C49D4A517D7

Q36397913-5307342C-BF2C-4A33-8DC6-70743BC7085C

Q36397913-5C6DA310-0E13-46CF-AEC2-CE15542353AE

Q36397913-5EADD774-8FDC-4F50-B822-11B06866F848

Q36397913-65CC8A04-531A-48EA-AC4B-6A15AB02458A

P304

Q36397913-963B9C81-1A61-4881-995C-D3CDE22172FF

P31

Q36397913-5EFACA8E-6640-4D3A-AD40-1E3409A90F3B

P356

Q36397913-88D69EF6-2C7E-464B-80A1-68CBFEA511AE

P433

Q36397913-FF710DDC-252A-464E-817C-C95D73590C3D

P478

Q36397913-C41AC2CF-C235-49E8-B0E9-37E6CB041489

P50

Q36397913-8A1B0EDB-6663-490B-9031-9DA2C59B8BB0

P577

Q36397913-3A61971F-3F98-432D-A269-CA88C5C74EB7

P698

Q36397913-E0D54B5D-B1AF-47DB-8304-317F1ABA6664

P921

Q36397913-EE5C1E42-6E03-4175-B986-7E2F29059F86

P932

Q36397913-CCFBDCE2-7AA1-4CDD-9E0E-35076D242A3C

P356

1740774515597688

P1433

Clinical Trials

P1476

Use of altered informed consent in pragmatic clinical research.

@en

P2093

Bray Patrick-Lake

http://www.w3.org/2001/XMLSchema#string

Brian Rath

http://www.w3.org/2001/XMLSchema#string

Daniel E Ford

http://www.w3.org/2001/XMLSchema#string

Hollie Schmidt

http://www.w3.org/2001/XMLSchema#string

John D Lantos

http://www.w3.org/2001/XMLSchema#string

Jonathan McCall

http://www.w3.org/2001/XMLSchema#string

Kevin Weinfurt

http://www.w3.org/2001/XMLSchema#string

Mark J Pletcher

http://www.w3.org/2001/XMLSchema#string

Ross E McKinney

http://www.w3.org/2001/XMLSchema#string

P2860

Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform

An ethics framework for a learning health care system: a departure from traditional research ethics and clinical ethics

Informed consent, comparative effectiveness, and learning health care

Quality improvement ethics: lessons from the SUPPORT study

Variability among institutional review boards' decisions within the context of a multicenter trial.

The QUIT-PRIMO provider-patient Internet-delivered smoking cessation referral intervention: a cluster-randomized comparative effectiveness trial: study protocol.

Antenatal consent in the SUPPORT trial: challenges, costs, and representative enrollment.

Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit.

Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials.

Exploring the ethical and regulatory issues in pragmatic clinical trials.

P304

494-502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1740774515597688

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Laura Mari Beskow

P577

2015-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26374677

http://www.w3.org/2001/XMLSchema#string

P921

informed consent

P932

4688909

http://www.w3.org/2001/XMLSchema#string